Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study

Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study

Introduction: Treatment-refractory, acute graft- versus -host disease (GvHD) of the lower gastrointestinal tract (GI) after allogeneic hematopoietic stem cell transplantation is life threatening and lacks effective treatment options. While fecal microbiota transplantation (FMT) was shown to ameliora...

Full description

Bibliographic Details
Main Authors: Walter Spindelboeck, Bettina Halwachs, Nadine Bayer, Bianca Huber-Krassnitzer, Eduard Schulz, Barbara Uhl, Lukas Gaksch, Stefan Hatzl, Victoria Bachmayr, Lisa Kleissl, Patrizia Kump, Alexander Deutsch, Georg Stary, Hildegard Greinix, Gregor Gorkiewicz, Christoph Högenauer, Peter Neumeister
Format: Article
Language:English
Published: SAGE Publishing 2021-12-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/20406207211058333

Internet

https://doi.org/10.1177/20406207211058333

Similar Items